SARC SARCOMA CLINICAL TRIALS

Spotlight

MIB Agents is now accepting Letters of Intent for the 2026 OutSmarting Osteosarcoma grants, with a submission deadline of October 24, 2025. Since 2017, this Family Fund–powered program has awarded $2.5 million to 32 investigators advancing research and hope for osteosarcoma patients.

Get Details »

October 9, 2025

MIB Agents Opens Applications for 2026 OutSmarting Osteosarcoma Research Grants

Osteosarcoma is a rare and aggressive bone cancer that affects roughly 1,000 people in the U.S. each year, half of them children and teens.

September 2, 2025

SARC to Host Semiannual Meeting at CTOS 2025 in Boca Raton

SARC is pleased to announce that our second semiannual meeting of 2025 will be held in conjunction with the Annual Meeting of the Connective Tissue Oncology Society (CTOS).

More SARC News

Where can I find a Sarcoma Center?

View locations

HOW CAN I FIND A SARC CLINICAL TRIAL?

See list of active SARC trials that are recruiting

Wednesday
Nov 12
2025

2025 SARC Semiannual Meeting as Part of CTOS
3:30 - 5:30 PM ET
Boca Raton, FL.

LEARN MORE

WHAT ARE SARCOMAS?

Sarcomas are uncommon and there are many different types — experts have identified more than 80 different forms — leading to significant diagnostic and therapeutic challenges. Sarcomas represent 15 to 20% of childhood cancers and 1% of adult cancers.

ABOUT SARCOMA

WHAT DOES SARC DO?

Founded in 2003 as a non-profit cancer research organization, SARC directly develops, sponsors, and manages research projects for pediatric and adult sarcomas. We lead domestic and international collaborative discovery, translational research, and clinical trials.

ABOUT SARC

WHO PARTNERS WITH SARC?

We collaborate with the scientific research community and sarcoma centers, partner with pharmaceutical and biotech companies, and provide patients and caregivers resources and information.

ABOUT SPONSORSHIP AND PARTNERSHIP OPPORTUNITIES

Home